Actively Recruiting
Study Comparing Single and Dual Antiplatelet Therapy in Older or High Bleeding Risk Patients Undergoing Coronary Intervention with Drug-Coated Balloons
Led by Fondazione Ricerca e Innovazione Cardiovascolare ETS · Updated on 2026-01-22
576
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of single antiplatelet therapy SAPT compared to dual antiplatelet therapy DAPT in elderly or high bleeding risk patients undergoing percutaneous coronary intervention PCI using the latest drug-coated balloon DCB. This international, multicenter, open-label randomized trial includes patients with stable or unstable coronary syndromes and aims to assess rates of ischemic and bleeding adverse events in this population. Participants will receive PCI treatment with the Essential Pro drug-coated balloon in coronary arteries of 2.0 to 4.0 mm diameter. After successful PCI, patients will be randomly assigned to either single antiplatelet therapy, where the investigator chooses aspirin or clopidogrel, or to dual antiplatelet therapy based on local standards and guidelines. The study will follow patients to compare outcomes of these two antiplatelet regimens. During the study, participants will be monitored for net adverse clinical events NACE over 12 months, including bleeding events categorized by a standardized bleeding scale and procedural success immediately after PCI. Researchers will collect data on patient-centered composite outcomes and safety measures. The total participation duration includes 12 months of follow-up to observe treatment effects and adverse events.
CONDITIONS
Brief Title
Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
Research Team
B
Bernardo Cortese, MD MSc
B
Beatrice Barbano
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here